Subcutaneous efalizumab is not effective in the treatment of alopecia areata.
Price VH, Hordinsky MK, Olsen EA, Roberts JL, Siegfried EC, Rafal ES, Korman NJ, Altrabulsi B, Leung HM, Garovoy MR, Caro I, Whiting DA.
Price VH, et al. Among authors: korman nj.
J Am Acad Dermatol. 2008 Mar;58(3):395-402. doi: 10.1016/j.jaad.2007.10.645.
J Am Acad Dermatol. 2008.
PMID: 18280336
Clinical Trial.